193 related articles for article (PubMed ID: 30144326)
41. Icariin ameliorates the progression of experimental autoimmune encephalomyelitis by down-regulating the major inflammatory signal pathways in a mouse relapse-remission model of multiple sclerosis.
Cong H; Zhang M; Chang H; Du L; Zhang X; Yin L
Eur J Pharmacol; 2020 Oct; 885():173523. PubMed ID: 32871176
[TBL] [Abstract][Full Text] [Related]
42. The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.
Leva G; Klein C; Benyounes J; Hallé F; Bihel F; Collongues N; De Seze J; Mensah-Nyagan AG; Patte-Mensah C
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3016-3027. PubMed ID: 28899788
[TBL] [Abstract][Full Text] [Related]
43. IBU-octyl-cytisine, a novel bifunctional compound eliciting anti-inflammatory and cholinergic activity, ameliorates CNS inflammation by inhibition of T-cell activity.
Nizri E; Irony-Tur-Sinai M; Lavon I; Meshulam H; Amitai G; Brenner T
Int Immunopharmacol; 2007 Sep; 7(9):1129-39. PubMed ID: 17630191
[TBL] [Abstract][Full Text] [Related]
44. HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis.
Sun Y; Chen H; Dai J; Zou H; Gao M; Wu H; Ming B; Lai L; Xiao Y; Xiong P; Xu Y; Gong F; Zheng F
J Neuroimmunol; 2015 Mar; 280():29-35. PubMed ID: 25773152
[TBL] [Abstract][Full Text] [Related]
45. Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis.
Garay L; Gonzalez Deniselle MC; Meyer M; Costa JJ; Lima A; Roig P; De nicola AF
Brain Res; 2009 Aug; 1283():177-85. PubMed ID: 19497309
[TBL] [Abstract][Full Text] [Related]
46. Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis.
Lee DH; Rötger C; Appeldoorn CC; Reijerkerk A; Gladdines W; Gaillard PJ; Linker RA
J Neuroimmunol; 2014 Sep; 274(1-2):96-101. PubMed ID: 25037177
[TBL] [Abstract][Full Text] [Related]
47. Lesional accumulation of RhoA(+) cells in brains of experimental autoimmune encephalomyelitis and multiple sclerosis.
Zhang Z; Schittenhelm J; Meyermann R; Schluesener HJ
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):231-40. PubMed ID: 17983427
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.
Talebi F; Ghorbani S; Chan WF; Boghozian R; Masoumi F; Ghasemi S; Vojgani M; Power C; Noorbakhsh F
J Neuroinflammation; 2017 Mar; 14(1):55. PubMed ID: 28302134
[TBL] [Abstract][Full Text] [Related]
49. Increased expression of colony-stimulating factor-1 in mouse spinal cord with experimental autoimmune encephalomyelitis correlates with microglial activation and neuronal loss.
Gushchina S; Pryce G; Yip PK; Wu D; Pallier P; Giovannoni G; Baker D; Bo X
Glia; 2018 Oct; 66(10):2108-2125. PubMed ID: 30144320
[TBL] [Abstract][Full Text] [Related]
50. Cerebrospinal fluid cholinergic biomarkers are associated with postoperative delirium in elderly patients undergoing Total hip/knee replacement: a prospective cohort study.
Lin X; Tang J; Liu C; Li X; Cao X; Wang B; Dong R; Xu W; Yu X; Wang M; Bi Y
BMC Anesthesiol; 2020 Sep; 20(1):246. PubMed ID: 32988381
[TBL] [Abstract][Full Text] [Related]
51. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
Hammer LA; Zagon IS; McLaughlin PJ
Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432
[TBL] [Abstract][Full Text] [Related]
52. Expression profiles of cholesterol metabolism-related genes are altered during development of experimental autoimmune encephalomyelitis in the rat spinal cord.
Lavrnja I; Smiljanic K; Savic D; Mladenovic-Djordjevic A; Tesovic K; Kanazir S; Pekovic S
Sci Rep; 2017 Jun; 7(1):2702. PubMed ID: 28578430
[TBL] [Abstract][Full Text] [Related]
53. Absence of system x
Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
[TBL] [Abstract][Full Text] [Related]
54. Traced on the Timeline: Discovery of Acetylcholine and the Components of the Human Cholinergic System in a Primitive Unicellular Eukaryote Acanthamoeba spp.
Baig AM; Rana Z; Tariq S; Lalani S; Ahmad HR
ACS Chem Neurosci; 2018 Mar; 9(3):494-504. PubMed ID: 29058403
[TBL] [Abstract][Full Text] [Related]
55. Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.
Li G; Yamasaki R; Fang M; Masaki K; Ochi H; Matsushita T; Kira JI
Sci Rep; 2018 Jan; 8(1):1933. PubMed ID: 29386552
[TBL] [Abstract][Full Text] [Related]
56. Capparis ovata treatment suppresses inflammatory cytokine expression and ameliorates experimental allergic encephalomyelitis model of multiple sclerosis in C57BL/6 mice.
Ozgun-Acar O; Celik-Turgut G; Gazioglu I; Kolak U; Ozbal S; Ergur BU; Arslan S; Sen A; Topcu G
J Neuroimmunol; 2016 Sep; 298():106-16. PubMed ID: 27609283
[TBL] [Abstract][Full Text] [Related]
57. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats.
Jee Y; Yoon WK; Okura Y; Tanuma N; Matsumoto Y
J Neuroimmunol; 2002 Jul; 128(1-2):49-57. PubMed ID: 12098510
[TBL] [Abstract][Full Text] [Related]
59. Differential expression of metallothioneins in the CNS of mice with experimental autoimmune encephalomyelitis.
Espejo C; Carrasco J; Hidalgo J; Penkowa M; Garcia A; Sáez-Torres I; Martínez-Cáceres EM
Neuroscience; 2001; 105(4):1055-65. PubMed ID: 11530242
[TBL] [Abstract][Full Text] [Related]
60. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
